What does Innovent Biologics, Inc. do?
Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other…
What is Innovent Biologics, Inc.'s P/E and P/B ratio?
Innovent Biologics, Inc. has a P/E ratio of 116.6 and a P/B ratio of 6.25.
What is Innovent Biologics, Inc.'s debt-to-equity ratio?
Innovent Biologics, Inc. has a debt-to-equity ratio of 0.11.
How much does Innovent Biologics, Inc. owe compared with what it owns?
Innovent Biologics, Inc. owes ¥0.48 for every ¥1 it owns (balance sheet Dec 2025), which is low.
What is Innovent Biologics, Inc.'s Positivity rank?
Innovent Biologics, Inc. is ranked #4,591 of 6,775 companies globally and #55 of 58 in China on PositoAI, with a Positivity Score of 19,273.
Does Innovent Biologics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Innovent Biologics, Inc..
Where can I read the latest news about Innovent Biologics, Inc.?
Recent headlines about Innovent Biologics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Innovent Biologics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Innovent Biologics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.